EN
TR
Colchicine treatment in recurrent subacute thyroiditis after Covid-19 and mRNA vaccination
Abstract
Subacute thyroiditis (SAT) is an inflammatory disease of the thyroid gland. It usually develops after a viral upper respiratory infection. It is often self-limited, but about 20% of cases are refractory to treatment with steroids. Steroid therapy is the first line of treatment for recurrent episodes of SAT. This letter reports that colchicine may be beneficial in two cases of recurrent SAT after covid-19 infection and mRNA vaccination.
Keywords
Kaynakça
- 1.Brancatella, A., Ricci, D., Viola, N., Sgrò, D., Santini, F., & Latrofa, F. (2020). Subacute Thyroiditis After Sars-COV-2 Infection. The Journal of clinical endocrinology and metabolism, 105(7), dgaa276. https://doi.org/10.1210/clinem/dgaa276
- 2.İremli, B. G., Şendur, S. N., & Ünlütürk, U. (2021). Three Cases of Subacute Thyroiditis Following SARS-CoV-2 Vaccine: Postvaccination ASIA Syndrome. The Journal of clinical endocrinology and metabolism, 106(9), 2600–2605. https://doi.org/10.1210/clinem/dgab373
- 3.Tian, Z., Su, Y., Zhang, M., Zhang, X., & Guan, Q. (2020). Successful Management of Recurrent Subacute Thyroiditis by Adding Colchicine to Glucocorticoid Treatment: A Case Series Study. Hormone and metabolic research, 52(10), 712–717. https://doi.org/10.1055/a-1148-2260
- 4.Bahçecioğlu, A. B., & Erdoğan, M. F. (2024). Colchicine as a Steroid-Sparing Agent in Relapsing and Steroid-Dependent Subacute Thyroiditis: Preliminary Observations. Thyroid : official journal of the American Thyroid Association, 34(11), 1444–1446
Ayrıntılar
Birincil Dil
İngilizce
Konular
Endokrinoloji
Bölüm
Mektup
Yayımlanma Tarihi
21 Nisan 2025
Gönderilme Tarihi
12 Mart 2025
Kabul Tarihi
27 Mart 2025
Yayımlandığı Sayı
Yıl 2025 Cilt: 1 Sayı: 1